Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Midhun Malla

GI Oncology · UAB

View

Dr. Gideon Dosunmu

GI Oncology · Emory Hospital Midtown

View

Dr. Diane Reidy-Lagunes

GI Oncology · Duke University

View

Dr. Tyler Johnson

GI Oncology · Stanford

View

Dr. James Cleary

GI Oncology · Dana-Farber Cancer Institute

View

Dr. Thorvardur Halfdanarson

GI Oncology · Mayo Clinic Rochester

View

Dr. Linette Bosques

GI Oncology · DFCI/MGB

View

Dr. Shikha Jain

GI Oncology · University Illinois

View

Dr. Talal Hilal

Lymphoma · Mayo Clinic College of Medicine

View

Dr. Saad Usmani

Myeloma · MSK

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    NADr. Nilofer Azad

    Dr. Nilofer Azad

    Hematology & Oncology · Gastrointestinal Oncology
    Johns Hopkins Medicine
    nilofer
    Feb 19, 2025Journal Article

    Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging.

    ​

    Written by 1 Roon author & 13 others

    Via Hepatology Communications

    Research

    Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting.

    2025

    Via Cancers

    Research

    Sustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and Chemotherapy.

    2025

    Via The American Surgeon

    Research

    Nivolumab and Relatlimab for the Treatment of Patients with Unresectable or Metastatic Mismatch Repair-Proficient Colorectal Cancer.

    2025

    Via Clinical Cancer Research

    Research

    ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1.

    2025

    Via eLife

    Research

    Spatial proteomics and transcriptomics reveal early immune cell organization in pancreatic intraepithelial neoplasia.

    2025

    Via JCI Insight

    Research

    Tumor site influences efficacy of MEKi and immunotherapy combinations in a preclinical model of cholangiocarcinoma.

    2025

    Via Hepatology

    Research

    Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.

    2025

    Via Clinical Cancer Research

    Research

    Safety and efficacy of intratumourally administered INT230-6 in adult patients with advanced solid tumours: results from an open-label phase 1/2 dose escalation study.

    2025

    Via EBioMedicine

    Research

    Neoadjuvant and adjuvant therapy for biliary tract cancer: Advances and limitations.

    2024

    Via Hepatology

    Research

    A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.

    2024

    Via International Journal of Cancer

    Research

    Surgical and local control outcomes after sequential short-course radiation therapy and chemotherapy for rectal cancer.

    2024

    Via Surgery Open Science

    Research

    Immunotherapy for the treatment of biliary tract cancer: an evolving landscape.

    2024

    Via Therapeutic Advances in Medical Oncology

    Research

    Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial.

    2024

    Via Clinical Cancer Research

    Research

    COMPANION-002 A clinical trial of investigational drug CTX-009 plus paclitaxel vs paclitaxel in second line advanced BTC.

    2024

    Via Future Oncology